SAB Biotherapeutics, Inc.

SAB Biotherapeutics SABSW shows preserved insulin production in early diabetes trial

# 📢 What This Document Is This is an **8-K filing**—a report public companies use to announce major news to investors. Here, SAB Biotherapeutics (ticker: SABS) is sharing **exciting new clinical trial data** that was just presented at a major medical conference. Think of it as a detailed press rele